Identification and Characterization of Circulating microRNAs as Diagnostic Biomarkers in Adolescent Idiopathic Scoliosis

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The aim of the present study is to evaluate the expression of a large panel of microRNAs, already known and validated in other ortopedic pathologies and bone metabolism, in the plasma of Adolescent Idiopathic Scoliosis (AIS) patients. The deregulated microRNAs identified will be then validated and computational analyzes will determine their potential involvement in the metabolism of bone and/or cartilage tissue in order to correlate the results obtained with the clinical data of the AIS patients. The investigators aimed to develop a microRNAs panel to further validate in a larger population of AIS patients in order to produce a device for the diagnosis and prognosis of Molecular-based AIS.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 11
Maximum Age: 17
Healthy Volunteers: t
View:

⁃ Cases:

• Age between 11-17 years

• Diagnosis of idiopathic scoliosis with a Cobb angle\> 10 °

• Minimum follow-up of two years

• Clinical data and radiological tests available and no surgical treatment prior to enrollment in the study

⁃ Controls:

• Age between 11-17 years

• Healthy subjects not affected by orthopedic and oncological diseases

Locations
Other Locations
Italy
Dipartimento Rizzoli-Sicilia
RECRUITING
Bagheria
Contact Information
Primary
Gianluca Giavaresi, MD
gianluca.giavaresi@ior.it
+39 051 6366730
Backup
Lavinia Raimondi, BSc PhD
lavinia.raimondi@ior.it
+39 327 3791290
Time Frame
Start Date: 2020-07-22
Estimated Completion Date: 2025-12-21
Participants
Target number of participants: 30
Treatments
Cases
20 patients with adolescent idiopathic scoliosis in a ratio of 5:1 between females and males will be enrolled.
Controls
10 healthy controls, of which 5 females and 5 males will be enrolled.
Sponsors
Leads: Istituto Ortopedico Rizzoli

This content was sourced from clinicaltrials.gov